Treatment of spinal muscular atrophy with Onasemnogene Abeparvovec in Switzerland: a prospective observational case series study.

Stettner GM, Hasselmann O, Tscherter A, Galiart E, Jacquier D, Klein A

Open source

DOI
10.1186/s12883-023-03133-6
Published
2023 Feb 28
Container
BMC neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12883-023-03133-6,
  title = {Treatment of spinal muscular atrophy with Onasemnogene Abeparvovec in Switzerland: a prospective observational case series study.},
  author = {Stettner GM and Hasselmann O and Tscherter A and Galiart E and Jacquier D and Klein A},
  year = {2023},
  journal = {BMC neurology},
  doi = {10.1186/s12883-023-03133-6},
  url = {https://doi.org/10.1186/s12883-023-03133-6}
}

RIS

TY  - JOUR
TI  - Treatment of spinal muscular atrophy with Onasemnogene Abeparvovec in Switzerland: a prospective observational case series study.
AU  - Stettner GM
AU  - Hasselmann O
AU  - Tscherter A
AU  - Galiart E
AU  - Jacquier D
AU  - Klein A
PY  - 2023
JO  - BMC neurology
DO  - 10.1186/s12883-023-03133-6
UR  - https://doi.org/10.1186/s12883-023-03133-6
ER  - 

APA

GM, S., O, H., A, T., E, G., D, J., & A, K. (2023). Treatment of spinal muscular atrophy with Onasemnogene Abeparvovec in Switzerland: a prospective observational case series study.. BMC neurology. https://doi.org/10.1186/s12883-023-03133-6

Source records